PCV2 immunogenic compositions and methods of producing such compositions

  • US 9,011,872 B2
  • Filed: 12/27/2012
  • Issued: 04/21/2015
  • Est. Priority Date: 12/30/2004
  • Status: Active Grant
First Claim
Patent Images

1. An immunogenic composition comprising an effective amount of recombinant PCV2 ORF2 protein, and an additional component selected from the group consisting of viral inactivators, inactivated viral vector, viral inactivator neutralizers, and combinations thereof, wherein said immunogenic composition provides a protective effect against clinical symptoms associated with a PCV2 infection after administration of a single dose thereof.

View all claims

    Thank you for your feedback